Ex vivo evaluation of the effect of plasma-derived factor VIII/von Willebrand factor in patients with severe hemophilia A on emicizumab prophylaxis. - Raventós A; Arias-Salgado EG; Pérez A; Alvarez-Román MT; Butta NV; Monzon Manzano E; Acuña P; Jiménez-Yuste V; Costa M; Bravo MI (CLINICAL AND EXPERIMENTAL MEDICINE, 2025)